DenvInD: dengue virus inhibitors database for clinical and molecular research

DevInD (Development of Industrial Drug molecules) is a specialized computational platform designed to provide comprehensive information and predictive models for drug molecules currently used or developed in the pharmaceutical industry. This resource serves as a centralized repository to assist researchers in understanding the chemical and biological properties of successful industrial drug candidates. Web Server: https://webs.iiitd.edu.in/raghava/denvind/ Citation Vivek Dhar Dwivedi, Aditya Arya, Pardeep Yadav, Rajesh Kumar, Vinod Kumar, Gajendra P S Raghava, DenvInD: dengue virus inhibitors database for clinical and molecular research, Briefings in Bioinformatics, Volume 22, Issue 3, May 2021, https://doi.org/10.1093/bib/bbaa098 About the Platform The pharmaceutical industry follows rigorous standards for selecting molecules with optimal pharmacokinetic and pharmacodynamic profiles. DevInD consolidates data on these "industrial-strength" molecules, which often differ significantly from common chemical libraries or early-stage leads. Data Compilation: The platform is built upon a manually curated dataset of drug molecules that have reached various stages of industrial development and clinical trials. Focus on Drug-Likeness: It emphasizes the structural features and molecular descriptors that contribute to a molecule's success in an industrial setting.